Deep Cultural Understanding
We help you connect with Indonesia's diverse cultures by navigating local habits, values, and unspoken norms. This ensures your strategy aligns with local expectations, building trust and fostering sustainable results.
With decades of experience, our firm excels in Indonesia's life science consulting, helping clients thrive in the competitive market. We offer a range of services with a global reach and hands-on support, tailored to navigate Indonesia's unique challenges.
Indonesia’s biotechnology segment within the life science sector reflects substantial expansion, with the biotechnology market valued at approximately USD 20 billion in 2025 and projected to grow at a compound annual growth rate (CAGR) of about 9.2% through 2032, reaching around USD 37 billion.
The pharmaceutical industry in Indonesia is also showing consistent growth. In 2025, the pharmaceuticals market reached an estimated USD 11 billion, driven by strong domestic demand and supported by universal healthcare coverage, while pharmaceutical output is expected to increase by 3.9% in 2026 and 5.8% in 2027.
Overall economic conditions contribute to this performance. In the first quarter of 2026, Indonesia’s overall GDP grew by 5.61%, while its manufacturing sector — which includes pharma and medical manufacturing — expanded by around 5.04%.
The projected CAGR for Indonesia's biotechnology market through 2032 is
Source: Indonesia Biotechnology Market Share, Companies & Trends Report 2025-2032
Indonesia's life science landscape is vibrant, encompassing pharmaceuticals, biotechnology, medical devices, healthcare services, nutraceuticals, diagnostics, agribusiness, bioinformatics, genomics, biomaterials, personalized medicine, telemedicine, clinical research, and epidemiology. Driven by innovation and governmental support, these sectors are experiencing rapid growth and transformation.
Our company offers reliable life science consulting in Indonesia, expertly navigating regulatory landscapes, technological advancements, and market dynamics. We leverage deep industry insights and strategic frameworks to empower decision-makers, optimize processes, and foster sustainable growth.
With trends such as digital health integration, personalized medicine, and AI-driven diagnostics, our tailored consulting services ensure clients are poised to seize opportunities and achieve their strategic objectives in the dynamic Indonesian life science environment.
We help you connect with Indonesia's diverse cultures by navigating local habits, values, and unspoken norms. This ensures your strategy aligns with local expectations, building trust and fostering sustainable results.
Our actionable intelligence, powered by real-time market monitoring and insights from your ecosystem, enables you to make informed decisions, seize emerging opportunities, and mitigate risks in Indonesia's dynamic markets.
Through direct engagement with key stakeholders, we provide you with nuanced perspectives that reveal the “why” behind market behaviors, helping you design tailored solutions that drive meaningful results.
Validate opportunities, manage risk, and allocate capital with greater confidence through current market evidence and practical strategic advice.
Our company has successfully supported various Life Science projects by providing market research, competitive analysis, and strategic guidance to help businesses succeed.
We offers comprehensive Life Science market research, delivering valuable insights and actionable recommendations in Indonesia to enable businesses to make well-informed decisions and achieve long-term success in the industry.
We offers comprehensive Life Science Strategic Planning services in Indonesia, providing tailored frameworks and actionable strategies to help businesses achieve their goals and sustain growth in a competitive environment.
We delivers expert Life Science Market Entry Strategy solutions in Indonesia, offering valuable insights and effective approaches that empower businesses to successfully penetrate new markets and secure a competitive edge.
We provides in-depth Life Science Merger and Acquisitions advisory in Indonesia, guiding businesses with expert recommendations to navigate complex transactions, unlock synergies, and maximize shareholder value.
We specializes in Life Science Value Chain Analysis in Indonesia, delivering actionable insights that optimize operational efficiency, enhance profitability, and drive strategic decision-making for businesses across industries.
We offers thorough Life Science Competitive Benchmarking services in Indonesia, helping businesses identify key performance gaps, uncover market opportunities, and build stronger competitive strategies.
We delivers expert Life Science Distribution and Strategic Partnership solutions in Indonesia, enabling businesses to establish effective networks, foster collaborative relationships, and achieve long-term market success.
We provides advanced Life Science Consumer Behavior Analysis services in Indonesia, offering actionable insights into consumer preferences and trends to help businesses refine their strategies and enhance customer satisfaction.
Establish industry dominance with our experts and partners
South China Morning Post featured Damien Duhamel, Managing Partner at Eurogroup Consulting, sharing his perspective on how Chinese EV competition could reshape Malaysia's automotive industry and the wider regional market.
At Transport Logistic Southeast Asia 2025, Mickael Feige, Partner at Eurogroup Consulting, moderated a fireside chat on building seamless, smart and sustainable supply chains for the new global economy.
Damien Duhamel shared his perspective with Business Insider on the factors shaping innovation across Asia's leading cities, from human talent and technology to governance and global integration.
Thailand’s ageing transition is creating a real but selective senior living opportunity. The paper examines investable demand, scalable business models and the constraints still limiting market growth.
Southeast Asia is emerging as a key advanced manufacturing hub. The white paper examines the capabilities, technologies and opportunities reshaping the region’s industrial landscape.
Southeast Asia’s cities are transforming through rapid urbanisation and sustainability. It explores the trends shaping greener, more resilient and inclusive urban development.
ASEAN’s consumer landscape is evolving with rising incomes, digitalisation and changing expectations. The report highlights the trends reshaping how businesses engage and grow across the region.
Regional pharmaceutical company — growing market presence in Indonesia
VIEW DETAILHIDE DETAIL →The client faced stringent regulatory requirements and complex approval processes impeding market expansion. They needed to streamline compliance and accelerate product authorization for new drug releases. Delays were affecting customer trust and competitive edge.
We conducted a detailed audit of current compliance procedures and collaborated on integrating digital tools to monitor regulatory changes. Our team provided specialized training sessions and developed a proactive communication framework with local authorities.
We advised on creating a compliance task force, leveraging technology to reduce manual processes, and establishing an early warning system for regulatory shifts. A risk assessment strategy was also put in place to anticipate regulatory obstacles.
Typical results include a 35% reduction in approval timeframes and cost savings in compliance management by 20%. The client reported improved relationships with regulatory bodies, enhancing their strategic position in the market.
National biotech firm — expanding production capabilities in Indonesia
VIEW DETAILHIDE DETAIL →The client struggled with inefficiencies in manufacturing operations that affected throughput and cost management. Demand for high-quality products necessitated an optimized production flow to meet market needs. Competition in the sector was also intensifying.
Our team analyzed existing workflows and implemented lean manufacturing principles tailored to the biotech context. We guided process re-engineering and introduced automation technologies to streamline operations.
Recommendations included launching a continuous improvement program, revising standard operating procedures, and deploying a real-time monitoring system. A focus was also placed on training staff to adapt to new technologies and methodologies.
Typical results showed a 25% increase in production output and a 15% reduction in operational costs. The engagement resulted in higher product consistency and enhanced capacity utilization.
Emerging medical device firm — entering the Indonesian market
VIEW DETAILHIDE DETAIL →The client needed a strategic approach for successfully launching their medical devices amidst regulatory barriers and competitive pressures. Establishing a robust distribution network and gaining brand recognition were critical challenges.
We crafted a market entry strategy that included comprehensive competitive analysis and segmented market research. Strategic partnerships were formed with local distributors to facilitate market penetration and regulatory approval processes.
Key recommendations involved targeting niche markets with specialized products, forming alliances with local healthcare providers, and enhancing online presence through digital marketing strategies. Regulatory advisory support was also integral to the plan.
Results typically included a 50% faster time-to-market for new devices and a 30% increase in market share within the first year. Enhanced brand awareness and stronger distribution channels contributed to sustained growth.
Trusted by clients for long-term collaboration. Selected organizations our teams have supported globally and across Indonesia.
A market study in the life science sector in Indonesia includes demand analysis, client segmentation, and competitor benchmarking. It might also involve regulatory review and field interviews to gather insights about consumer preferences, compliance requirements, and emerging market trends, which help identify strategic opportunities.
Conducting a feasibility study is essential to assess the potential success of entering the Indonesian life science market. It involves market potential analysis, financial viability assessment, and risk evaluation. By understanding barriers such as regulatory challenges and local competition, companies can make informed decisions and mitigate risks.
Market size in Indonesian life science consulting is assessed through quantitative and qualitative analyses. This includes evaluating sales data, forecasting future trends, and analyzing demographic information. Expert interviews and review of industry reports help confirm insights, providing a comprehensive view of market opportunities and growth potential.
A competitive analysis in Indonesia’s life science sector involves identifying key players, assessing their market share, and understanding their strategies. Techniques like competitor benchmarking, SWOT analysis, and evaluating pricing and distribution channels provide insights. This helps companies refine their own strategy and build a sustainable competitive advantage.
Benchmarking in the Indonesian life science sector involves comparing business processes and performance metrics against industry standards. Techniques such as performance metric analysis, best practice identification, and peer comparison are used to identify gaps, optimize operations, and enhance productivity, ensuring alignment with market leaders.
600 N Bridge Rd, #13-06, Singapore 188778